• A
• B
• C
• D
• E
• F
• G
• H
• I
• K
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Atezolizumab (Tecentriq®) in combination with carboplatin and etoposide for 1L ES-SCLC HTA ID: 19030

Autologous anti-CD19-transduced CD3+ cells (Tecartus®). HTA ID: 21005

Avacopan (Tavneos®). HTA ID: 22009

Avanafil (Spedra®)

Avatrombopag (Doptelet®). HTA ID: 20006

Avatrombopag (Doptelet®). HTA ID: 20058

Avelumab (Bavencio®)

Avelumab (Bavencio®) 1L maintenance urothelial carcinoma. HTA ID: 21001

Avelumab (Bavencio®) in combination with axitinib (Inlyta®) for first line treatment of metastatic renal cell carcinoma. HTA ID: 19046

Axicabtagene Ciloleucel (Yescarta®)